Use of allikor for the normalization of fibrinolysis and hemostasis in patients with chronic cerebrovascular diseases;Ispol'zovanie allikora dlia normalizatsii sistem fibrinoliza i gemostaza u bol'nykh s khronicheskoi tserebrovaskuliarnoi patologiei.

Klinicheskaia meditsina

Volumn 79, Issue 11, 2001, Pages 55-58

  Andrianova, I V ^a   Ionova, V G ^a   Demina, E G ^a   Shabalina, A A ^a   Karabasova, I A ^a   Liutova, L I ^a   Povorinskaia, T E ^a   Orekhov, A N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; PLANT MEDICINAL PRODUCT;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FIBRINOLYSIS; GARLIC; HEMOSTASIS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ARTERIOSCLEROSIS; CHRONIC DISEASE; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; GARLIC; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 2242472747     PISSN: 00232149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)